Ethics & Informed Consent: Prospective Cohort Study (Finland)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Prospective Cohort Study being conducted in Finland, study designs must align with the primary regulatory legislation: Medical Research Act (488/1999). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional National Advisory Board on Social Welfare and Health Care Ethics (ETENE). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Prospective Cohort Study, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Minimal to Moderate Risk (Observational)

This longitudinal design monitors cohorts prospectively. Informed consent documents must disclose future follow-up intervals and secure medical database linking rules.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: STROBE guidelines.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Finnish Data Protection Act (Tietosuojalaki).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing National Advisory Board on Social Welfare and Health Care Ethics (ETENE) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Passive tracking in this Prospective Cohort Study in Finland relies on beneficence in research ethics to balance data utility with privacy. Ensuring database security is essential when the study involves vulnerable populations research ethics protections. Observational researchers must submit a secure informed consent template research form detailing electronic data pathways. The PI must secure formal institutional review board approval from the National Advisory Board on Social Welfare and Health Care Ethics (ETENE) before extracting any clinical records. Without any animal protocols under the animal research ethics 3rs, the application focuses on human clinical data security. All records and signed consent sheets must reside on secure local servers in Finland to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions